AAAAAA
Results:
1-10
|
Results: 10
Authors:
Sternberg, CN
de Mulder, PHM
Schornagel, JH
Theodore, C
Fossa, SD
van Oosterom, AT
Witjes, F
Spina, M
van Groeningen, CJ
de Balincourt, C
Collette, L
Citation: Cn. Sternberg et al., Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy amd recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European organization for research and treatment of cancerprotocol no. 30924, J CL ONCOL, 19(10), 2001, pp. 2638-2646
Authors:
van den Bongard, HJGD
Mathot, RAA
Boogerd, W
Schornagel, JH
Soesan, M
Schellens, JHM
Beijnen, JH
Citation: Hjgd. Van Den Bongard et al., Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure, CANC CHEMOT, 47(6), 2001, pp. 537-540
Authors:
Schrama, JG
Baars, JW
Holtkamp, MJ
Schornagel, JH
Beijnen, JH
Rodenhuis, S
Citation: Jg. Schrama et al., Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer, BONE MAR TR, 28(2), 2001, pp. 173-180
Authors:
Detmar, SB
Muller, MJ
Wever, LDV
Schornagel, JH
Aaronson, NK
Citation: Sb. Detmar et al., Patient-physician communication during outpatient palliative treatment visits - An observational study, J AM MED A, 285(10), 2001, pp. 1351-1357
Authors:
de Gast, GC
Klumpen, HJ
Vyth-Dreese, FA
Kersten, MJ
Verra, NCV
Sein, J
Batchelor, D
Nooijen, WJ
Schornagel, JH
Citation: Gc. De Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma, CLIN CANC R, 6(4), 2000, pp. 1267-1272
Authors:
Detmar, SB
Aaronson, NK
Wever, LDV
Muller, M
Schornagel, JH
Citation: Sb. Detmar et al., How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues, J CL ONCOL, 18(18), 2000, pp. 3295-3301
Authors:
van Groeningen, CJ
Peters, GJ
Schornagel, JH
Gall, H
Noordhuis, P
de Vries, MJ
Turner, SL
Swart, MS
Pinedo, HM
Hanauske, AR
Giaccone, G
Citation: Cj. Van Groeningen et al., Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors, J CL ONCOL, 18(14), 2000, pp. 2772-2779
Authors:
Westermann, AM
Holtkamp, MMJ
Linthorst, GAM
van Leeuwen, L
Willemse, EJM
van Dijk, WC
Nooijen, WJ
Baars, JW
Schornagel, JH
Rodenhuis, S
Citation: Am. Westermann et al., At home management of aplastic phase following high-dose chemotherapy withstem-cell rescue for hematological and non-hematological malignancies, ANN ONCOL, 10(5), 1999, pp. 511-517
Authors:
Panday, VRN
de Wit, R
Schornagel, JH
Schot, M
Rosing, H
Lieverst, J
Huinink, WWT
Schellens, JHM
Beijnen, JH
Citation: Vrn. Panday et al., Pharmacokinetics of paclitaxel administered in combination with cisplatin,etoposide and bleomycin in patients with advanced solid tumours, CANC CHEMOT, 44(4), 1999, pp. 349-353
Authors:
Sneeuw, KCA
Aaronson, NK
Sprangers, MAG
Detmar, SB
Wever, LDV
Schornagel, JH
Citation: Kca. Sneeuw et al., Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses, BR J CANC, 81(1), 1999, pp. 87-94
Risultati:
1-10
|